Hayley Amie C, Ogeil Rowan P, Faulkner Agatha, Beard Naomi, Downey Luke A, Smith Karen, Lubman Dan I, Scott Deborah
Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia.
Institute for Breathing and Sleep, Austin Health, Melbourne, Australia.
J Stud Alcohol Drugs. 2023 Jan;84(1):128-136. doi: 10.15288/jsad.22-00050.
Amphetamine-type stimulants are increasingly implicated in road trauma incidents. Although ambulances are typically first to attend these emergencies, limited research has used paramedic clinical data to examine the contribution of amphetamine use to road trauma-related ambulance attendances. We describe the clinical and temporal risk profiles associated with amphetamine-related harm in road trauma incidents requiring paramedic attendance in the Australian state of Victoria.
This cross-sectional, retrospective observational study examined the Victorian component of a national surveillance data set (National Ambulance Surveillance System) of alcohol and other drug (AOD)-related ambulance attendances to determine the incidence and temporal profile of amphetamine use in traffic-related ambulance attendances from January 2015 to December 2020.
Throughout the observation period, Victorian paramedics attended 8,163 alcohol, pharmaceutical, or illicit drug-related cases involving a road trauma. More than one quarter (2,161 cases, 27.4%) of these attendances were deemed related to the use of pharmaceutical and/or illicit drugs. Amphetamine alone was involved in nearly one third (640 cases, 29.6%) of non-alcohol-related road trauma attendances, and co-consumption of amphetamine with drugs other than alcohol occurred in more than one third (35.3%) of all AOD-related traffic incidents. Amphetamine-related road trauma attendances predominantly occurred on the weekend (Fri-Sun) during late night/early morning in metropolitan Melbourne. Between 2015 and 2020, the incidence of amphetamine-related road trauma ambulance attendances increased by 86.8%, from 1.1 per 100,000 population in 2015 to 1.9 per 100,000 population in 2020.
Amphetamine-type stimulants are increasingly implicated in road trauma. Co-consumption with other potentially impairing substances reflects a concerning trend of polysubstance use among Victorian drivers.
苯丙胺类兴奋剂与道路交通事故的关联日益增加。尽管救护车通常是首批赶赴这些紧急情况的，但利用护理人员临床数据来研究苯丙胺使用对道路创伤相关救护车出勤情况影响的研究有限。我们描述了在澳大利亚维多利亚州需要护理人员出勤的道路创伤事件中，与苯丙胺相关伤害有关的临床和时间风险概况。
这项横断面回顾性观察研究，对一个全国性酒精和其他药物（AOD）相关救护车出勤监测数据集（国家救护车监测系统）中的维多利亚州部分进行了检查，以确定2015年1月至2020年12月期间与交通相关的救护车出勤中苯丙胺使用的发生率和时间概况。
在整个观察期内，维多利亚州的护理人员共出勤了8163起涉及道路创伤的酒精、药物或非法药物相关病例。其中超过四分之一（2161例，27.4%）的出勤被认为与药物和/或非法药物的使用有关。仅苯丙胺就涉及近三分之一（640例）的非酒精相关道路创伤出勤（29.6%），并且在所有与AOD相关的交通事件中，超过三分之一（35.3%）的情况是苯丙胺与酒精以外的其他药物共同使用。与苯丙胺相关的道路创伤出勤主要发生在墨尔本大都市区周末（周五至周日）的深夜/凌晨。2015年至2020年期间，与苯丙胺相关的道路创伤救护车出勤发生率增加了86.8%，从2015年的每10万人1.1例增至2020年的每10万人1.9例。
苯丙胺类兴奋剂与道路创伤的关联日益增加。与其他可能损害功能的物质共同使用，反映出维多利亚州驾驶员中多物质使用这一令人担忧的趋势。
